Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Zhigang C. Wang(Dana-Farber Cancer Institute), Matthew Schwede(Stanford University), Anna DeFazio(Peter MacCallum Cancer Centre), David D.L. Bowtell(The University of Melbourne), Kathryn E. Daniels(Brigham and Women's Hospital), Kathryn Alsop(Peter MacCallum Cancer Centre), Joyce F. Liu(Duke University), Alexander Miron(Harvard University), Ronny Drapkin(University of Pennsylvania), Nicolai J. Birkbak(Brigham and Women's Hospital), Aedín C. Culhane(Harvard University), John Quackenbush(Harvard University), Ross S. Berkowitz(Dana-Farber Brigham Cancer Center), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Ruiyang Tian(Brigham and Women's Hospital), Gillian Mitchell(Peter MacCallum Cancer Centre), Helga B. Salvesen(Haukeland University Hospital), J. Dirk Iglehart(Brigham and Women's Hospital), Aquila Fatima(Dana-Farber Cancer Institute), Huiying Piao(Brigham and Women's Hospital)
Clinical Cancer Research
August 22, 2012
10.1158/1078-0432.ccr-12-0857
Cited by 162

Related Papers

The Immune Landscape of Cancer
|Immunity|2018|6.2k
The complete genome sequence of the gastric pathogen Helicobacter pylori
|Nature|1997|3.6k
Mutational Processes Molding the Genomes of 21 Breast Cancers
|Cell|2012|2k
The landscape of cancer genes and mutational processes in breast cancer
|Nature|2012|1.7k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k